Showing results (71-80 of 185) with videos related to
Sort By:
Pageof 19
Current Medicinal Chemistry. Anti-Cancer Agents|April 8, 2003
Peptidomimetic design of CDK inhibitors targeting the recruitment site of the cyclin subunitCampbell McInnes, Martin J I Andrews, Daniella I Zheleva, et al.Current Medicinal Chemistry. Anti-Cancer Agents|July 23, 2003
Anti-epidermal growth factor receptor strategies to enhance radiation actionG LammeringCurrent Medicinal Chemistry. Anti-Cancer Agents|July 23, 2003
Membrane targeted anticancer drugs: potent inducers of apoptosis and putative radiosensitisersV Jendrossek, R HandrickCurrent Medicinal Chemistry. Anti-Cancer Agents|September 24, 2004
Antitumor pharmacology -- quo vadis?Christian Bailly, Jean-Marc Barret, Anna KruczynskiCurrent Medicinal Chemistry. Anti-Cancer Agents|September 24, 2004
A rational selection of drug targets needs deeper insights into general regulation mechanismsGiovanni CapranicoCurrent Medicinal Chemistry. Anti-Cancer Agents|September 24, 2004
Prospects for hypoxia-activated anticancer drugsWilliam A DennyCurrent Medicinal Chemistry. Anti-Cancer Agents|September 24, 2004
Modelling and simulation: a computational perspective in anticancer drug discoveryFederico GagoCurrent Medicinal Chemistry. Anti-Cancer Agents|March 22, 2005
Monoclonal antibody-based targeted therapy in breast cancerKadri Altundag, Francisco J Esteva, Banu ArunCurrent Medicinal Chemistry. Anti-Cancer Agents|October 8, 2003
GnRH agonists and antagonists in cancer therapyMurty V Chengalvala, Jeffrey C Pelletier, Gregory S KopfCurrent Medicinal Chemistry. Anti-Cancer Agents|July 5, 2005
Lanthanide bearing microparticulate systems for multi-modality imaging and targeted therapy of cancerS W Zielhuis, J F W Nijsen, J H Seppenwoolde, et al.Pageof 19